SLI
2.040,02
PKT
-7,44
PKT
-0,36
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.12.06 | Novartis | DZ-Bank | |
| 15.12.06 | Nestlé | DZ-Bank | |
| 15.12.06 | Nestlé overweight | Morgan Stanley | |
| 14.12.06 | Nestlé akkumulieren | Independent Research | |
| 14.12.06 | Novartis buy | SEB | |
| 27.12.06 | Novartis | Zürcher Kantonalbank | |
| 14.12.06 | Novartis buy | Bank Sarasin & Cie | |
| 12.12.06 | Novartis equal-weight | Morgan Stanley | |
| 12.12.06 | Swiss Life Marketperformer | LB Rheinland-Pfalz | |
| 08.12.06 | Adecco SA kaufen | Fuchsbriefe | |
| 08.12.06 | Swisscom halten | Wertpapier | |
| 08.12.06 | Zurich Insurance | DZ-Bank | |
| 08.12.06 | Novartis | DZ-Bank | |
| 08.12.06 | Nestlé | DZ-Bank | |
| 06.12.06 | Holcim | Zürcher Kantonalbank | |
| 04.12.06 | Holcim reduzieren | Independent Research | |
| 01.12.06 | Novartis neutral | JP Morgan | |
| 01.12.06 | Zurich Insurance | DZ-Bank | |
| 01.12.06 | Novartis | DZ-Bank | |
| 01.12.06 | Nestlé | DZ-Bank | |
| 05.12.06 | Novartis buy | Jyske Bank | |
| 30.11.06 | Nestlé buy | UBS | |
| 29.11.06 | UBS equal-weight | Morgan Stanley | |
| 29.11.06 | UBS overweight | Morgan Stanley | |
| 29.11.06 | Novartis buy | Bank Sarasin & Cie | |
| 01.12.06 | Richemont halten | Hamburger Sparkasse | |
| 30.11.06 | Novartis kaufen | Helaba Trust | |
| 30.11.06 | Novartis equal-weight | Morgan Stanley | |
| 28.11.06 | Zurich Insurance overweight | JP Morgan | |
| 28.11.06 | UBS overweight | JP Morgan | |
| 27.11.06 | Holcim | Wirtschaftswoche | |
| 24.11.06 | Zurich Insurance | DZ-Bank | |
| 24.11.06 | Novartis | DZ-Bank | |
| 24.11.06 | Nestlé | DZ-Bank | |
| 23.11.06 | Givaudan outperform | HypoVereinsbank | |
| 22.11.06 | Holcim buy | Banque SYZ & CO | |
| 21.11.06 | Adecco SA halten | Hamburger Sparkasse | |
| 21.11.06 | Adecco SA overweight | Morgan Stanley | |
| 20.11.06 | Zurich Insurance overweight | JP Morgan | |
| 17.11.06 | Novartis equal-weight | Morgan Stanley |